Europe Pharmaceutical Excipients Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Pharmaceutical Excipients Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Pharmaceutical Excipients Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Pharmaceutical Excipients Market Regional Analysis

6.2 Europe Pharmaceutical Excipients Market Revenue 2020-2028 (US$ Million)

6.3 Europe Pharmaceutical Excipients Market Forecast Analysis

7. Europe Pharmaceutical Excipients Market Analysis – by Product

7.1 Organic Chemicals

7.1.1 Overview
7.1.2 Organic Chemicals: Europe Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Inorganic Chemicals

7.2.1 Overview
7.2.2 Inorganic Chemicals: Europe Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Other Products

7.3.1 Overview
7.3.2 Other Products: Europe Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Europe Pharmaceutical Excipients Market Analysis – by Functionality

8.1 Fillers and Diluents

8.1.1 Overview
8.1.2 Fillers and Diluents: Europe Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Suspending and Viscosity Agents

8.2.1 Overview
8.2.2 Suspending and Viscosity Agents: Europe Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Coating Agents

8.3.1 Overview
8.3.2 Coating Agents: Europe Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.4 Binders

8.4.1 Overview
8.4.2 Binders: Europe Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.5 Preservatives

8.5.1 Overview
8.5.2 Preservatives: Europe Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.6 Emulsifying Agents

8.6.1 Overview
8.6.2 Emulsifying Agents: Europe Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.7 Other Functionalities

8.7.1 Overview
8.7.2 Other Functionalities: Europe Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Europe Pharmaceutical Excipients Market Analysis – by Type of Formulation

9.1 Oral Formulations

9.1.1 Overview
9.1.2 Oral Formulations: Europe Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Topical Formulations

9.2.1 Overview
9.2.2 Topical Formulations: Europe Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Parenteral Formulations

9.3.1 Overview
9.3.2 Parenteral Formulations: Europe Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.4 Other Formulations

9.4.1 Overview
9.4.2 Other Formulations : Europe Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Europe Pharmaceutical Excipients Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Pharmaceutical Excipients Market Breakdown, by Key Country, 2023 and 2028 (%)
10.2.1.1 Europe Pharmaceutical Excipients Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 UK: Europe Pharmaceutical Excipients Market Breakdown, by Product
10.2.1.1.2 UK: Europe Pharmaceutical Excipients Market Breakdown, by Functionality
10.2.1.1.3 UK: Europe Pharmaceutical Excipients Market Breakdown, by Type of Formulation

10.2.1.2 Germany: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Germany: Europe Pharmaceutical Excipients Market Breakdown, by Product
10.2.1.2.2 Germany: Europe Pharmaceutical Excipients Market Breakdown, by Functionality
10.2.1.2.3 Germany: Europe Pharmaceutical Excipients Market Breakdown, by Type of Formulation

10.2.1.3 France: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 France: Europe Pharmaceutical Excipients Market Breakdown, by Product
10.2.1.3.2 France: Europe Pharmaceutical Excipients Market Breakdown, by Functionality
10.2.1.3.3 France: Europe Pharmaceutical Excipients Market Breakdown, by Type of Formulation

10.2.1.4 Russia: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.4.1 Russia: Europe Pharmaceutical Excipients Market Breakdown, by Product
10.2.1.4.2 Russia: Europe Pharmaceutical Excipients Market Breakdown, by Functionality
10.2.1.4.3 Russia: Europe Pharmaceutical Excipients Market Breakdown, by Type of Formulation

10.2.1.5 Italy: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.5.1 Italy: Europe Pharmaceutical Excipients Market Breakdown, by Product
10.2.1.5.2 Italy: Europe Pharmaceutical Excipients Market Breakdown, by Functionality
10.2.1.5.3 Italy: Europe Pharmaceutical Excipients Market Breakdown, by Type of Formulation

10.2.1.6 Rest of Europe: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Pharmaceutical Excipients Market Breakdown, by Product
10.2.1.6.2 Rest of Europe: Europe Pharmaceutical Excipients Market Breakdown, by Functionality
10.2.1.6.3 Rest of Europe: Europe Pharmaceutical Excipients Market Breakdown, by Type of Formulation

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Archer-Daniels-Midland Co

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 AshLand Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Avantor Inc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 BASF SE

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Evonik Industries AG

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 JRS PHARMA GmbH & Co. KG

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 MEGGLE GmbH & Co KG

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Roquette Freres SA

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 The Dow Chemical Co

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 The Lubrizol Corp

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Pharmaceutical Excipients Market